However, despite the much higher viral load, the EV treatment did not approach the highly significant, complete phenotypic rescue (restoring TH levels to > 110%) observed with the much lower-dose Fbxo7 vector.
← all excerpts
rAAV Fbxo7 gene therapy rescues the progressive nigrostriatal pathology in a mouse model of juvenile parkinsonism.
1
—
—